Macromoltek

Computational antibody design

·Health & Fitness·YC Winter 2018·tracked since Sep 25, 2026
WatchVisit site ↗
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders

About Macromoltek

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Discover more startups

Browse the board →